B-Cell Lymphomas Coverage from Every Angle

Tycel J. Phillips, MD, on Administering Glofitamab Monotherapy to Patients With Mantle Cell Lymphoma

Posted: Thursday, January 5, 2023

Tycel J. Phillips, MD, of the City of Hope National Medical Center, discusses what new findings on glofitamab could mean for outcomes in patients with relapsed or refractory mantle cell lymphoma who have received obinutuzumab pretreatment.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.